Testing Services Revenue was CareDx’s largest region in fiscal 2025, bringing in $273.38M of $359.94M (76%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Testing Services Revenue | $262.96M | — | $209.16M | $248.25M | $273.38M | ||||||
| Service | — | — | — | — | — | ||||||
| Testing Services | — | — | — | — | — | ||||||
| Patient & Digital Solutions Revenue | — | — | $36.72M | $43.46M | $56.65M | ||||||
| Patient & Digital Solutions | $28.18M | — | — | — | — | ||||||
| Product Revenue | $16.41M | — | $19.75M | $26.02M | $29.91M | ||||||
| Product | — | — | — | — | — | ||||||
| Allosure Kidney | — | $7.80M | — | — | — | ||||||
| Digital & Other Revenue | — | — | — | — | — | ||||||
| License & Other | — | — | — | — | — | ||||||
| Digital & Other | — | — | — | — | — | ||||||
| Royalty | — | — | — | — | — | ||||||
| Total | $307.54M | $7.80M | $265.63M | $317.73M | $359.94M |
CareDx brought in $359.94M from its three regions in fiscal 2025, the year ended December 31, 2025. That was up 13.3% from $317.73M in fiscal 2024. Testing Services Revenue was the largest at $273.38M (76.0%), ahead of Patient & Digital Solutions Revenue at $56.65M (15.7%) and Product Revenue at $29.91M (8.3%).
Compared with fiscal 2024, Patient & Digital Solutions Revenue grew fastest, up 30.4% to $56.65M. Every region above 2% of revenue grew.
CareDx began breaking out Patient & Digital Solutions Revenue in fiscal 2023, when it brought in $36.72M. CareDx stopped reporting Patient & Digital Solutions ($28.18M in fiscal 2022) and Allosure Kidney ($7.80M in fiscal 2023) as separate regions.
United States was CareDx’s largest region in fiscal 2025, bringing in $273.38M of $291.85M (94%).
| Geography | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $262.96M | $209.16M | $248.25M | $273.38M | |||||||
| North America | — | — | — | — | |||||||
| Rest Of World | $8.46M | $13.76M | $14.76M | $18.47M | |||||||
| Europe | $18.63M | — | — | — | |||||||
| Rest Of The World | — | — | — | — | |||||||
| Australia | — | — | — | — | |||||||
| Total | $290.05M | $222.92M | $263.01M | $291.85M |
CareDx brought in $291.85M from its two regions in fiscal 2025, the year ended December 31, 2025. That is less than the $359.94M it reports by geography, so these regions do not cover all of its revenue. United States was the largest at $273.38M (93.7%), ahead of Rest Of World at $18.47M (6.3%).
Compared with fiscal 2024, Rest Of World grew 25.1% to $18.47M and United States grew 10.1% to $273.38M.
CareDx stopped reporting Europe as a separate region after fiscal 2022, when it brought in $18.63M.
CareDx (CDNA) reports its revenue by geography. In fiscal 2025, Testing Services Revenue was its largest region, bringing in $273.38M (76.0% of the total), followed by Patient & Digital Solutions Revenue at $56.65M (15.7%).
Testing Services Revenue was CareDx's largest region in fiscal 2025, bringing in $273.38M, or 76.0% of the $359.94M total across its three regions.
Among CareDx's regions that make up at least 2% of revenue, Patient & Digital Solutions Revenue grew fastest in fiscal 2025, up 30.4% from $43.46M to $56.65M.
Every figure comes from CareDx's annual financial filings, as reported. Each line keeps the name CareDx gives it, and years follow its fiscal calendar.
CareDx's revenue by geography goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.